The Cambridge urology clinical trials team was initiated in 2011 with the primary goal of building up the local NIHR and commercial urology trials portfolio within the Department of Urology.

Since our inception in 2011 the aim of CU-TRACT has been to grow our portfolio of studies. We started with one clinical trial and have been privileged in the last 10 years to have been involved in over 30 trials ranging from benign and reconstructive urology to urological cancer studies, inclusive of prostate, bladder and kidney. We have successfully been top recruiters for half of these studies and been able to network with teams nationally and worldwide.

In 2014 the Cambridge Urology Translational Research and Clinical Trials (CUTRACT) office was established with the aim of consolidating the diverse research undertaken in urology in Cambridge. CUTRACT has been highly successful, bringing in over £2.0M in research funding and recruitment of over 1600 patients into a diverse range of studies.

CUTRACT has also initiated a number of investigator-led trials within the team in addition to this portfolio. To date CUTRACT has successfully led, conducted and completed 3 multi-center trials recruiting >700 patients. The CUTRACT team would be very pleased to hear from academic NIHR or commercial partners who would like to explore urological research trials in Cambridge. Our own investigator led research has meant that we have been able to coordinate studies as the sponsor and outreach to national sites. This has meant that we have successfully organised training days and have been able to present results of these studies at conferences such as BAUS, EAU, SIU and BAUN and bagged various awards and accolades. Teaching is incredibly important to the team and as such, we spend time teaching our peers in order to work harmoniously together in the clinical setting. Alongside this we run a yearly (at present) informed decision-making day which can be seen here.